epileptic seizure
Scope
Date
~
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...
Nov 16, 2023 (Gmt+09:00)
-
Sports
Another Foreigner Detained in China, This Time a Korean Soccer Pro
SINGAPORE—Chinese police have detained a South Korean soccer player on allegations of bribery, the latest in a spate of enforcement actions af...
May 22, 2023 (Gmt+09:00)
-
Cryptocurrencies
Terra co-founder Do Kwon’s $177 million assets in Korea under seizure
Terraform Labs co-founder Do Kwon, the mastermind behind the Terra-Luna cryptocurrency collapse, has had most of his assets in South Korea frozen, a...
May 11, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals wins Red Dot award for 2 devices
South Korea’s SK Biopharmaceuticals on Tuesday said two of its self-developed wearable devices won the main prize in the health care category ...
Apr 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK invests in US digital healthcare firm Cala Health
South Korea's SK Biopharmaceuticals Co. has dipped its toes into the rapidly growing digital healthcare market by investing in Cala Health, a US-bas...
May 19, 2022 (Gmt+09:00)
Latest News
- 1 Korea’s top cinema chains seek merger to counter box office slump
- 2 S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
- 3 CJ CheilJedang to open $72 mn dumpling plant in Japan
- 4 LG Electronics breaks ground on $600 million home appliance plant in India
- 5 KakaoBank posts record Q1 profit, eyes Thai expansion after Indonesia